Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)

被引：1
|
作者：
Khasraw, M. [1 ]
Abrey, L. E. [1 ]
Lassman, A. B. [1 ]
Hormigo, A. [1 ]
Nolan, C. [1 ]
Gavrilovic, I. T. [1 ]
Mellinghoff, I. K. [1 ]
Reiner, A. S. [1 ]
DeAngelis, L. M. [1 ]
Omuro, A. M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.2065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2065
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas
    Minniti, Giuseppe
    Scaringi, Claudia
    De Sanctis, Vitaliana
    Lanzetta, Gaetano
    Falco, Teresa
    Di Stefano, Domenica
    Esposito, Vincenzo
    Enrici, Riccardo Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (02) : 187 - 194
  • [32] A PHASE I/II STUDY OF VORINOSTAT PLUS DAILY TEMOZOLOMIDE AND BEVACIZUMAB IN THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Janney, Dorothea E.
    Peters, Katherine
    Sampson, John
    Gururangan, Sri
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2010, 12 : 73 - 73
  • [33] VORINOSTAT, BEVACIZUMAB, AND METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE GLIOMA: A PHASE I/II CLINICAL TRIAL
    Peters, Katherine B.
    Reardon, David A.
    Vredenburgh, James J.
    Desjardins, Annick
    Herndon, James E., II
    Coan, April
    McSherry, Frances
    Lipp, Eric
    Brickhouse, Alise
    Massey, Woody
    Friedman, Henry S.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
  • [34] A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL
    Gilbert, Mark
    Yuan, Ying
    Wani, Khalida
    Wu, Jimin
    Omuro, Antonio
    Lieberman, Frank
    Robins, H. Ian
    Gerstner, Elizabeth
    Wu, Jing
    Wen, Patrick
    Mikkelsen, Tom
    Armstrong, Terri
    Aldape, Ken
    NEURO-ONCOLOGY, 2014, 16
  • [35] Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment
    Lee, Jung-Min
    Annunziata, Christina M.
    Hays, John L.
    Cao, Liang
    Choyke, Peter
    Yu, Minshu
    An, Daniel
    Turkbey, Ismail Baris
    Minasian, Lori M.
    Steinberg, Seth M.
    Chen, Helen
    Wright, John
    Kohn, Elise C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 88 - 94
  • [36] Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
    Quinn, Jennifer A.
    Jiang, Sara Xiaoyin
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Friedman, Allan H.
    Bigner, Darell D.
    Sampson, John H.
    McLendon, Roger E.
    Herndon, James E., II
    Walker, Amy
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1262 - 1267
  • [37] Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial
    Nystrom, ML
    Steele, JPC
    Shamash, J
    Neville, F
    Oliver, RTD
    MELANOMA RESEARCH, 2003, 13 (02) : 197 - 199
  • [38] Bevacizumab versus bevacizumab plus vorinostat in adults with recurrent malignant glioma: Results of a phase I part of a phase I/II trial
    Wu, Jing
    Groves, Morris D.
    Gilbert, Mark R.
    Hess, Kenneth R.
    Loch, Carolyn Sue
    Ictech, Sandra
    De Groot, John Frederick
    Conrad, Charles A.
    Yung, W. K. Alfred
    Puduvalli, Vinay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Multicenter Phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG).
    Lin, Xuling
    Kaley, Thomas Joseph
    Pentsova, Elena
    DeAngelis, Lisa Marie
    Daras, Mariza
    Gavrilovic, Igor T.
    Mellinghoff, Ingo K.
    McKeown, Andrew
    Manne, Malbora
    Hansen, Jessica
    Bavisotto, Linda M.
    Gorman, Greg
    Lamson, Michael
    Karmali, Rashida A.
    Omuro, Antonio Marcilio Padula
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Phase I/II study of BIBW 2992 with or without daily temozolomide in the treatment of patients with recurrent malignant glioma
    Reardon, D. A.
    Fu, Y.
    Thurm, H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345